Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Cadila Healthcare

Sector: Healthcare | Industry: Drugs & Pharma
R 247.45 9.40  | 3.95% -39.28% 14.96 25,312.04
NSE Price: Sep 20, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Sep 20, 15:59 247.45 9.40 3.95% 238.00 238.05 1,626,395 234.65 - 249.55
BSE Sep 20, 2019 247.25 9.50 4.00% 238.00 237.75 80,546 234.85 - 249.40
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 2,199,438 P/B: 2.37 NSE Code: CADILAHC
52-Week Range: R 206.50 - 414.80 Dividend Yield: 1.42% BSE Code: 532321
TTM EPS: R 16.53 Book Value: R 104.53 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Lupin (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 37 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Cadila Healthcare -28.99 12.81 2.02 -39.19 -14.29 -0.81 14.16
S&P BSE Mid Cap* -13.95 -1.72 -8.02 -16.28 0.39 6.13 7.96
S&P BSE Healthcare* -8.71 1.32 1.60 -19.82 -8.39 -1.90 12.18
Company's return has been calculated on basis of NSE's price.
As on Sep 20, 2019
*As on Sep 19, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 10.13 11.78 12.75
Net Profit 5.96 -1.22 17.23
EPS 4.11 -1.49 18.13
Book Value 18.78 22.15 24.74
Average
Operating Margin 24.11 23.52 23.49
Net Margin 13.85 14.63 15.53
Return on Networth 19.36 21.68 26.90
Return on Investment 15.88 16.88 20.49
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -6.34 20.82 -6.34
Operating Profit -21.96 -12.29 -21.96
Net Profit -34.31 -29.92 -34.31
EPS -34.02 -34.07 -34.02
TTM
Revenue 4.58 9.16 4.58
Operating Profit -2.89 -9.59 -2.89
Net Profit -7.26 -17.12 -7.26
EPS -8.49 -19.37 -8.49
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Cadila Healthcare 25,312.04 13,768.20 1,717.40 12.36 19.36 2.37 14.96
Lupin 34,224.68 17,280.63 711.14 4.01 4.55 2.48 48.42
Torrent Pharmaceuticals 29,226.58 7,823.00 489.00 6.21 9.34 5.92 59.77
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 04, 2019 Zydus Family Trust  Buy Market 17,500 230.25 40.29
Sep 04, 2019 Zydus Family Trust  Buy Market 250,723 230.25 577.29
Sep 03, 2019 Zydus Family Trust  Buy Market 17,420 228.95 39.88
Sep 03, 2019 Zydus Family Trust  Buy Market 234,428 228.95 536.72
Aug 30, 2019 Zydus Family Trust  Buy Market 7,427 225.25 16.73
Fund Houses invested in the stock
Fund Jun-19 Mar-19 Dec-18 Sep-18 Jun-18
Kotak Mahindra Mutual Fund 1.905 1.078 0.856 0.847 0.647
Franklin Templeton Mutual Fund 1.636 1.568 1.553 1.549 1.560
UTI Mutual Fund 1.016 0.736 0.738 0.633 0.470
Reliance Mutual Fund 0.687 0.594 0.435 0.435 0.183
ICICI Prudential Mutual Fund 0.614 0.355 0.386 0.383 0.062
IDFC Mutual Fund 0.483 0.347 0.508 0.324 0.257
DSP Mutual Fund 0.445 0.020 0.134 0.211 0.499
Aditya Birla Sun Life Mutual Fund 0.266 0.141 0.164 0.087 -
SBI Mutual Fund 0.118 0.182 0.177 0.235 0.227
L&T Mutual Fund 0.082 - 0.020 0.049 -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Cadila Healthcare Ltd.

Address: Zydus Corporate Park, Scheme No.63, Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle, Sarkhej - Gandhinagar Highway, Ahmedabad, Gujarat - 382481 | Phone: 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20 | Fax: 079- 26862365

Email: [email protected]

Website: www.zyduscadila.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: 506-508, 5th Floor, Amaranth Business Complex - I (ABC - I)Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura, Ahmedabad - 380009, 506-508, 5th Floor, Amaranth Business Complex - I (ABC - I), Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road, Navrangpura

Essential checks
Altman Z-Score
2.94
Piotroski F-Score
4
Modified C-Score
2
5-Years Price to Earnings
14.96
5-Years Price to Book
2.37
Earnings Yield
EBIT / Enterprise value
7.59%
PEG
Price / Earnings to growth ratio
1.05
Related Stocks
  Current Price   Chng %
Abbott India R10,219.15 +3.88%
Alkem Laboratories R1,948.20 +4.36%
Biocon R228.05 +0.33%
Glaxosmithkline Pharma R1,384.20 -0.82%
Ipca Laboratories R956.10 +0.87%
Lupin R756.30 +2.03%
Pfizer R3,267.85 +0.72%
Sanofi India R5,890.20 +3.91%
Syngene International R317.80 +2.50%
Torrent Pharmaceuticals R1,727.20 +1.47%
As on Sep 20, 15:59